Bosworth, Hayden BGranger, Bradi BMendys, PhilBrindis, RalphBurkholder, RebeccaCzajkowski, Susan MDaniel, Jodi GEkman, IngerHo, MichaelJohnson, MimiKimmel, Stephen ELiu, Larry ZMusaus, JohnShrank, William HWhalley Buono, ElizabethWeiss, KarenGranger, Christopher B2024-02-012024-02-012011-090002-87031097-6744https://hdl.handle.net/10161/30062Poor adherence to efficacious cardiovascular-related medications has led to considerable morbidity, mortality, and avoidable health care costs. This article provides results of a recent think-tank meeting in which various stakeholder groups representing key experts from consumers, community health providers, the academic community, decision-making government officials (Food and Drug Administration, National Institutes of Health, etc), and industry scientists met to evaluate the current status of medication adherence and provide recommendations for improving outcomes. Below, we review the magnitude of the problem of medication adherence, prevalence, impact, and cost. We then summarize proven effective approaches and conclude with a discussion of recommendations to address this growing and significant public health issue of medication nonadherence.HumansCardiovascular DiseasesCardiovascular AgentsMorbiditySurvival RateCommunity Health ServicesCommunity Pharmacy ServicesDrug CostsFees, PharmaceuticalUnited StatesMedication AdherenceJournal article